小切口开胸手术与全胸腔镜治疗早期非小细胞肺癌的临床效果及安全性分析

Analysis of Clinical Effect and Safety of Mini-thoracotomy Surgery and Totally Thoracoscopic Surgery in Treatment of Early Stage Non-small-cell Lung Cancer

目的主要分析在早期非小细胞肺癌患者的治疗中行小切口开胸手术与全胸腔镜治疗的有效性。方法收集因早期非小细胞肺癌疾病到该院进行手术医治的患者为研究成员,其收集的起始时间为2016年5月,终止时间为2017年3月,从中抽取56例,按照数量对等原则进行平均分组,其中予以小切口开胸手术进行医治的28例患者为小切口组,开展全胸腔镜医治的28例患者为胸腔镜组,对所有病患治疗后的手术时间、术中失血量、胸腔引流量、术后带胸管时间、淋巴结清扫数量并发症发生情况以及住院时间等予以整理与记录,进而评价其治疗的有效性。结果胸腔镜组病患手术时间(109.3±24.7)min、术中失血量(79.2±19.9)m L、胸腔引流量(181.6±29.4)m L、术后带胸管时间(5.0±0.5)d、术后并发症发生例数为3例,住院时间为(9.5±2.0)d均少于小切口组(P<0.05)。小切口组病患淋巴结清扫数量为(14.2±4.6)个,胸腔镜组病患淋巴结清扫数量为(14.6±4.9)个,二者之间差异无统计学意义(P>0.05)。结论于早期非小细胞肺癌疾病中运用全胸腔镜手术方式以及小切口开胸手术方式均有较好的治疗效果,但开展全胸腔镜手术对病患机体的损伤性相对较低,并发症发生情况较少,因而在该疾病的相关医治中全胸腔镜医治方式值得推荐。

Objective To mainly analyze the effectiveness of mini-thoracotomy surgery and totally thoracoscopic surgery in treatment of early stage non-small-cell lung cancer. Methods 56 cases of patients with early stage non-small-cell lung cancer from May 2016 to March 2017 were selected and divided into two groups with 28 cases in each,respectively treated with mini-thoracotomy surgery and totally thoracoscopic surgery, and the operation time, intraoperative bleeding amount, thoracic drainage amount, thoracic tube placement time after surgery, occurrence of complications of lymph node dissection numbers and length of stay were recorded and sorted up and the treatment effectiveness was further evaluated. Results The operation time, intraopeative bleeding amount, thoracic drainage amount, thoracic tube placement time after surgery, occurrence case of postoperative complications and length of stay in the thoracic group were respectively（109.3 ±24.7）marks,（79.2 ±19.9）m L,（181.6 ±29.4）m L,（5.0 ±0.5）d 3 cases and（9.5 ±2.0）d,（P 〈0.05）, and the lymph node dissection number in the small incision group and in the thoracic group between the two groups was statistically significant[（14.2±4.6） vs（14.6±4.9）]（P〉0.05）. Conclusion The treatment effect of mini-thoracotomy surgery and totally thoracoscopic surgery in treatment of early stage non-small-cell lung cancer is better, but the injury of totally thoracoscopic surgery on the disease organs is relatively low with few complications, and it is worth recommendation in the related treatment.